EDP Sciences logo
Authentification abonné
Rechercher
Menu
Accueil Tous les numéros Volume 34 (October 2018) Focus issue F1 Med Sci (Paris), 34 (2018) 121-133 Références
Accès gratuit
Numéro
Med Sci (Paris)
Volume 34, October 2018
Cancer biomarkers
Page(s) 121 - 133
DOI https://doi.org/10.1051/medsci/201834f121
Publié en ligne 7 novembre 2018
  1. Valeyre D. et al. Sarcoidosis. Lancet 2014 ; 383 : 9923 1155–1167. [CrossRef] [PubMed] [Google Scholar]
  2. Iannuzzi M.C. Rybicki B.A. Teirstein A.S. Sarcoidosis. N Engl J Med 2007 ; 357 : 21 2153–2165. [CrossRef] [PubMed] [Google Scholar]
  3. Baughman R.P. et al. Clinical characteristics of patients in a case control study of sarcoidosis. Am J Respir Crit Care Med 2001 ; 164 : 10 Pt 1 1885–1889. [CrossRef] [PubMed] [Google Scholar]
  4. Mana J. et al. Cutaneous involvement in sarcoidosis. Relationship to systemic disease. Arch Dermatol 1997 ; 133 : 7 882–888. [Google Scholar]
  5. Lodha S. Sanchez M. Prystowsky S. Sarcoidosis of the skin: a review for the pulmonologist. Chest 2009 ; 136 : 2 583–596. [CrossRef] [PubMed] [Google Scholar]
  6. Costabel U. Guzman J. Baughman R.P. Systemic evaluation of a potential cutaneous sarcoidosis patient. Clin Dermatol 2007 ; 25 : 3 303–311. [CrossRef] [PubMed] [Google Scholar]
  7. Chappell A.G. Cheung W.Y. Hutchings H.A. Sarcoidosis: a long-term follow up study. Sarcoidosis Vasc Diffuse Lung Dis 2000 ; 17 : 2 167–173. [PubMed] [Google Scholar]
  8. Broos C.E. et al. Granuloma Formation in Pulmonary Sarcoidosis. Frontiers in Immunology 2013 ; 4 : 437. [CrossRef] [PubMed] [Google Scholar]
  9. Lockstone H.E. et al. Gene set analysis of lung samples provides insight into pathogenesis of progressive, fibrotic pulmonary sarcoidosis. Am J Respir Crit Care Med 2010 ; 181 : 12 1367–1375. [CrossRef] [PubMed] [Google Scholar]
  10. Swigris J.J. et al. Sarcoidosis-related mortality in the United States from 1988 to 2007. Am J Respir Crit Care Med 2011 ; 183 : 11 1524–1530. [CrossRef] [PubMed] [Google Scholar]
  11. Huang C.T. et al. Mortality in sarcoidosis. A changing pattern of the causes of death. Eur J Respir Dis 1981 ; 62 : 4 231–238. [PubMed] [Google Scholar]
  12. Arcasoy S.M. et al. Characteristics and outcomes of patients with sarcoidosis listed for lung transplantation. Chest 2001 ; 120 : 3 873–880. [CrossRef] [PubMed] [Google Scholar]
  13. Iwai K. et al. Racial difference in cardiac sarcoidosis incidence observed at autopsy. Sarcoidosis 1994 ; 11 : 1 26–31. [PubMed] [Google Scholar]
  14. Brownell I. et al. Evidence for mycobacteria in sarcoidosis. Am J Respir Cell Mol Biol 2011 ; 45 : 5 899–905. [CrossRef] [PubMed] [Google Scholar]
  15. Gupta D. et al. Molecular evidence for the role of mycobacteria in sarcoidosis: a meta-analysis. Eur Respir J 2007 ; 30 : 3 508–516. [CrossRef] [PubMed] [Google Scholar]
  16. Newman L.S. et al. A case control etiologic study of sarcoidosis: environmental and occupational risk factors. Am J Respir Crit Care Med 2004 ; 170 : 12 1324–1330. [CrossRef] [PubMed] [Google Scholar]
  17. Chen E.S. Moller D.R. Sarcoidosis–scientific progress and clinical challenges. Nat Rev Rheumatol 2011 ; 7 : 8 457–467. [CrossRef] [PubMed] [Google Scholar]
  18. Zhou Y. et al. Human leukocyte antigen-A, -B, and -DRB1 alleles and sarcoidosis in Chinese Han subjects. Hum Immunol 2011 ; 72 : 7 571–575. [CrossRef] [PubMed] [Google Scholar]
  19. Grunewald J. Eklund A. Role of CD4+ T cells in sarcoidosis. Proc Am Thorac Soc 2007 ; 4 : 5 461–464. [CrossRef] [Google Scholar]
  20. Piotrowski W.J. et al. TGF-beta and SMADs mRNA Expression in Pulmonary Sarcoidosis. Adv Exp Med Biol 2015 ; 852 : 59–69. [CrossRef] [PubMed] [Google Scholar]
  21. Judson, M.A., et al., Molecular profiling and gene expression analysis in cutaneous sarcoidosis: the role of interleukin-12, interleukin-23, and the T-helper 17 pathway. J Am Acad Dermatol, 2012. 66(6): p. 901–10, 910.e1-2. [CrossRef] [PubMed] [Google Scholar]
  22. Piotrowski, W.J., et al., Expression of HIF-1A/VEGF/ING-4 Axis in Pulmonary Sarcoidosis. Adv Exp Med Biol, 2015. [Google Scholar]
  23. Imai H. Kaira K. Minato K. Clinical significance of post-progression survival in lung cancer. Thorac Cancer 2017 ; 8 : 379–386. [CrossRef] [PubMed] [Google Scholar]
  24. Crouser E.D. et al. Gene expression profiling identifies MMP-12 and ADAMDEC1 as potential pathogenic mediators of pulmonary sarcoidosis. Am J Respir Crit Care Med 2009 ; 179 : 10 929–938. [CrossRef] [PubMed] [Google Scholar]
  25. Eickhoff S.B. et al. Analysis of neurotransmitter receptor distribution patterns in the cerebral cortex. Neuroimage 2007 ; 34 : 4 1317–1330. [CrossRef] [PubMed] [Google Scholar]
  26. Chen, E.S. and D.R. Moller, Etiologies of Sarcoidosis. Clin Rev Allergy Immunol, 2015. [Google Scholar]
  27. Ma Y. Gal A. Koss M.N. The pathology of pulmonary sarcoidosis: update. Semin Diagn Pathol 2007 ; 24 : 3 150–161. [CrossRef] [PubMed] [Google Scholar]
  28. Morgenthau A.S. Iannuzzi M.C. Recent advances in sarcoidosis. Chest 2011 ; 139 : 1 174–182. [CrossRef] [PubMed] [Google Scholar]
  29. Rybicki B.A. et al. Familial risk ratio of sarcoidosis in African-American sibs and parents. Am J Epidemiol 2001 ; 153 : 2 188–193. [CrossRef] [Google Scholar]
  30. Rybicki B.A. et al. Racial differences in sarcoidosis incidence: a 5-year study in a health maintenance organization. Am J Epidemiol 1997 ; 145 : 3 234–241. [CrossRef] [Google Scholar]
  31. Sverrild A. et al. Heredity in sarcoidosis: a registry-based twin study. Thorax 2008 ; 63 : 10 894–896. [CrossRef] [PubMed] [Google Scholar]
  32. Newman L.S. et al. A case control etiologic study of sarcoidosis: environmental and occupational risk factors. Am J Respir Crit Care Med 2004 ; 170 : 12 1324–1330. [CrossRef] [PubMed] [Google Scholar]
  33. Crouser E.D. et al. Differential expression of microRNA and predicted targets in pulmonary sarcoidosis. Biochem Biophys Res Commun 2012 ; 417 : 2 886–891. [CrossRef] [Google Scholar]
  34. Loke W.S.J. Herbert C. Thomas P.S. Sarcoidosis: Immunopathogenesis and Immunological Markers. International Journal of Chronic Diseases 2013 ; 2013 : 13. [Google Scholar]
  35. Ringkowski S. Thomas P.S. Herbert C. Interleukin-12 family cytokines and sarcoidosis. Front Pharmacol 2014 ; 5 : 233. [PubMed] [Google Scholar]
  36. Naumnik, W., et al., Interleukin-33 as a New Marker of Pulmonary Sarcoidosis. Adv Exp Med Biol, 2015. [Google Scholar]
  37. Fischer, A., et al., Identification of Immune-relevant Factors Conferring Sarcoidosis Genetic Risk. Am J Respir Crit Care Med, 2015. [Google Scholar]
  38. Mana J. et al. Granulomatous cutaneous sarcoidosis: diagnosis, relationship to systemic disease, prognosis and treatment. Sarcoidosis Vasc Diffuse Lung Dis 2013 ; 30 : 4 268–281. [PubMed] [Google Scholar]
  39. Kaarteenaho-Wiik R. Soini Y. Claudin-1, -2, -3, -4, -5, and -7 in Usual Interstitial Pneumonia and Sarcoidosis. Journal of Histochemistry and Cytochemistry 2009 ; 57 : 3 187–195. [CrossRef] [Google Scholar]
  40. Hidaka K. et al. An adjacent pair of human NUDT genes on chromosome X are preferentially expressed in testis and encode two new isoforms of diphosphoinositol polyphosphate phosphohydrolase. J Biol Chem 2002 ; 277 : 36 32730–32738. [CrossRef] [PubMed] [Google Scholar]
  41. Foley P.J. et al. Analysis of MHC encoded antigen-processing genes TAP1 and TAP2 polymorphisms in sarcoidosis. Am J Respir Crit Care Med 1999 ; 160 : 3 1009–1014. [CrossRef] [PubMed] [Google Scholar]
  42. Foley P. et al. HLA-DPB1 and TAP1 polymorphisms in sarcoidosis. Chest 1997 ; 111 : 6 Suppl 73S. [CrossRef] [PubMed] [Google Scholar]
  43. Gungor S. et al. Conventional markers in determination of activity of sarcoidosis. Int Immunopharmacol 2015 ; 25 : 1 174–179. [CrossRef] [PubMed] [Google Scholar]
  44. Wessendorf T.E. Bonella F. Costabel U. Diagnosis of Sarcoidosis. Clin Rev Allergy Immunol 2015 ; 49 : 1 54–62. [CrossRef] [PubMed] [Google Scholar]
  45. Li S. Sun X. Miao S. Liu J. Jiao W. Differential protein-coding gene and long noncoding RNA expression in smoking-related lung squamous cell carcinoma. Thorac Cancer 2017 ; 8 : 672–681. [CrossRef] [PubMed] [Google Scholar]

Les statistiques affichées correspondent au cumul d'une part des vues des résumés de l'article et d'autre part des vues et téléchargements de l'article plein-texte (PDF, Full-HTML, ePub... selon les formats disponibles) sur la platefome Vision4Press.

Les statistiques sont disponibles avec un délai de 48 à 96 heures et sont mises à jour quotidiennement en semaine.

Le chargement des statistiques peut être long.